DLHAX
Price
$22.65
Change
-$0.08 (-0.35%)
Updated
May 23 closing price
Net Assets
649.2M
JFNIX
Price
$63.69
Change
-$0.08 (-0.13%)
Updated
May 23 closing price
Net Assets
4.66B
Interact to see
Advertisement

DLHAX vs JFNIX

Header iconDLHAX vs JFNIX Comparison
Open Charts DLHAX vs JFNIXBanner chart's image
Macquarie Healthcare A
Price$22.65
Change-$0.08 (-0.35%)
VolumeN/A
Net Assets649.2M
Janus Henderson Global Life Sciences I
Price$63.69
Change-$0.08 (-0.13%)
VolumeN/A
Net Assets4.66B
DLHAX vs JFNIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DLHAX vs. JFNIX commentary
May 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLHAX is a Hold and JFNIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.66B vs. DLHAX (649M). JFNIX pays higher dividends than DLHAX: JFNIX (0.39) vs DLHAX (0.10). DLHAX was incepted earlier than JFNIX: DLHAX (18 years) vs JFNIX (16 years). DLHAX (1.25) is less costly to investors than JFNIX (0.77). JFNIX is a more actively managed with annual turnover of: 35.00 vs. DLHAX (5.00). DLHAX has a lower initial minimum investment than JFNIX: DLHAX (1000) vs JFNIX (2500). JFNIX annual gain was more profitable for investors over the last year : -13.66 vs. DLHAX (-15.94). JFNIX return over 5 years is better than : 6.67 vs. DLHAX (-15.27).
DLHAXJFNIXDLHAX / JFNIX
Total Expense Ratio1.210.77157%
Annual Report Gross Expense Ratio1.250.77162%
Fund Existence18 years16 years-
Gain YTD-4.632-6.36673%
Front Load6%N/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets649M4.66B14%
Annual Yield % from dividends0.100.3925%
Returns for 1 year-15.94-13.66117%
Returns for 3 years-12.155.99-203%
Returns for 5 years-15.276.67-229%
Returns for 10 years10.468.11129%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBHCX14.100.05
+0.36%
Neuberger Berman Equity Income C
GEMSX22.330.02
+0.09%
Goldman Sachs Emerging Markets Eq Svc
GLNCX20.92-0.03
-0.14%
MFS Global New Discovery C
TMVIX23.02-0.08
-0.35%
Timothy Plan Large/Mid Cap Value I
APGCX58.44-0.61
-1.03%
AB Large Cap Growth C